Relationship between different anti-rheumatic drug therapies and complementary and alternative medicine in patients with rheumatoid arthritis: an interview based cross-sectional study.

Almalag, Haya M; Almuhareb, Aseel M; Alsharafi, Aya A; Alhawassi, Tariq M; Alghamdi, Ahmed A; Alarfaj, Hussain; Omair, Mohammed A; Alomari, Bedor A; Alblowi, Maysoon S; Abouzaid, Hanan H; Alarfaj, Abdurhman S

Almalag, Haya M; Almuhareb, Aseel M; Alsharafi, Aya A; Alhawassi, Tariq M; Alghamdi, Ahmed A; Alarfaj, Hussain; Omair, Mohammed A; Alomari, Bedor A; Alblowi, Maysoon S; Abouzaid, Hanan H; Alarfaj, Abdurhman S.

Afiliación

Almalag HM; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Almuhareb AM; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alsharafi AA; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alhawassi TM; Department of Clinical Pharmacy and Medication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alghamdi AA; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alarfaj H; Rheumatology Unit, Department of Medicine, King Saud University Medical City, Riyadh, Saudi Arabia.
Omair MA; Rheumatology Unit, Department of Medicine, King Saud University Medical City, Riyadh, Saudi Arabia.
Alomari BA; Rheumatology Clinical Pharmacist, Department of Pharmaceutical Service, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Alblowi MS; Rheumatology Unit, Department of Medicine, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Abouzaid HH; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alarfaj AS; Rheumatology Unit, Department of Medicine, King Saud University Medical City, Riyadh, Saudi Arabia.

Saudi Pharm J ; 29(5): 462-466, 2021 May.

Article en En | MEDLINE | ID: mdl-34135672

Palabras clave

Anti-rheumatic therapies; CAM practices; CAM, complementary and alternative medicine; Chronic illness; Disease activity; HAQ, health assessment questionnaire; HCQ, hydroxychloroquine; LEF, leflunomide; MTX, Methotrexate; Patient safety; RA, rheumatoid arthritis; Rheumatoid arthritis; SSZ, sulfasalazine; TNFi, tumour necrosis factor inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Saudi Pharm J Año: 2021 Tipo del documento: Article País de afiliación: Arabia Saudita

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google